313 related articles for article (PubMed ID: 10052969)
21. Substrate-induced stable enzyme-inhibitor complex formation allows tight binding of novel 2-aminopyrimidin-4(3H)-ones to drug-resistant HIV-1 reverse transcriptase mutants.
Samuele A; Facchini M; Rotili D; Mai A; Artico M; Armand-Ugón M; Esté JA; Maga G
ChemMedChem; 2008 Sep; 3(9):1412-8. PubMed ID: 18465760
[TBL] [Abstract][Full Text] [Related]
22. Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.
Radi M; Maga G; Alongi M; Angeli L; Samuele A; Zanoli S; Bellucci L; Tafi A; Casaluce G; Giorgi G; Armand-Ugon M; Gonzalez E; Esté JA; Baltzinger M; Bec G; Dumas P; Ennifar E; Botta M
J Med Chem; 2009 Feb; 52(3):840-51. PubMed ID: 19140683
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
Yu M; Li Z; Liu S; Fan E; Pannecouque C; De Clercq E; Liu X
ChemMedChem; 2011 May; 6(5):826-33. PubMed ID: 21322110
[TBL] [Abstract][Full Text] [Related]
24. Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-ones.
He Y; Chen F; Yu X; Wang Y; De Clercq E; Balzarini J; Pannecouque C
Bioorg Chem; 2004 Dec; 32(6):536-48. PubMed ID: 15530994
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
[TBL] [Abstract][Full Text] [Related]
26. Dihydro-alkoxyl-benzyl-oxopyrimidine derivatives (DABOs) as non-nucleoside reverse transcriptase inhibitors: an update review (2001-2011).
Yang S; Chen FE; De Clercq E
Curr Med Chem; 2012; 19(2):152-62. PubMed ID: 22320294
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.
Gu SX; Yang SQ; He QQ; Ma XD; Chen FE; Dai HF; Clercq ED; Balzarini J; Pannecouque C
Bioorg Med Chem; 2011 Dec; 19(23):7093-9. PubMed ID: 22037050
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
[TBL] [Abstract][Full Text] [Related]
29. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
[TBL] [Abstract][Full Text] [Related]
30. 4-Benzyl and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones: in vitro evaluation of new C-3-amino-substituted and C-5,6-alkyl-substituted analogues against clinically important HIV mutant strains.
Benjahad A; Croisy M; Monneret C; Bisagni E; Mabire D; Coupa S; Poncelet A; Csoka I; Guillemont J; Meyer C; Andries K; Pauwels R; de Béthune MP; Himmel DM; Das K; Arnold E; Nguyen CH; Grierson DS
J Med Chem; 2005 Mar; 48(6):1948-64. PubMed ID: 15771439
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Liang YH; Feng XQ; Zeng ZS; Chen FE; Balzarini J; Pannecouque C; De Clercq E
ChemMedChem; 2009 Sep; 4(9):1537-45. PubMed ID: 19591191
[TBL] [Abstract][Full Text] [Related]
32. 5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a series of anti-HIV-1 agents of the dihydro-alkoxy-benzyl-oxopyrimidine family with peculiar structure-activity relationship profile.
Nawrozkij MB; Rotili D; Tarantino D; Botta G; Eremiychuk AS; Musmuca I; Ragno R; Samuele A; Zanoli S; Armand-Ugón M; Clotet-Codina I; Novakov IA; Orlinson BS; Maga G; Esté JA; Artico M; Mai A
J Med Chem; 2008 Aug; 51(15):4641-52. PubMed ID: 18630898
[TBL] [Abstract][Full Text] [Related]
33. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of pyrimidine and quinolone conjugates as a scaffold for dual inhibitors of HIV reverse transcriptase and integrase.
Wang Z; Vince R
Bioorg Med Chem Lett; 2008 Feb; 18(4):1293-6. PubMed ID: 18226894
[TBL] [Abstract][Full Text] [Related]
35. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 13: synthesis of fluorine-containing diaryltriazine derivatives for in vitro anti-HIV evaluation against wild-type strain.
Xiong YZ; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2009 Apr; 6(4):561-8. PubMed ID: 19353537
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
Qin H; Liu C; Guo Y; Wang R; Zhang J; Ma L; Zhang Z; Wang X; Cui Y; Liu J
Bioorg Med Chem; 2010 May; 18(9):3231-7. PubMed ID: 20371182
[TBL] [Abstract][Full Text] [Related]
37. 2-(2,6-Dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Rao A; Balzarini J; Carbone A; Chimirri A; De Clercq E; Monforte AM; Monforte P; Pannecouque C; Zappalà M
Antiviral Res; 2004 Aug; 63(2):79-84. PubMed ID: 15302136
[TBL] [Abstract][Full Text] [Related]
38. New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
Le Van K; Cauvin C; de Walque S; Georges B; Boland S; Martinelli V; Demonté D; Durant F; Hevesi L; Van Lint C
J Med Chem; 2009 Jun; 52(12):3636-43. PubMed ID: 19469474
[TBL] [Abstract][Full Text] [Related]
39. Nitroimidazoles. V. Synthesis and anti-HIV evaluation of new 5-substituted piperazinyl-4-nitroimidazole derivatives.
Al-Soud YA; Al-Masoudi NA; Hassan HG; De Clercq E; Pannecouque C
Acta Pharm; 2007 Dec; 57(4):379-93. PubMed ID: 18165184
[TBL] [Abstract][Full Text] [Related]
40. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
